Indchemie | Pioneering Pharmaceutical Innovation & Quality

International Business

Overview

Indchemie gradually transforming from primarily India focused firm into a diversified global player with current deep footprint in Emerging market. With new accreditations and strategic partnership help us to serve millions in more than 26 countries. Strong Pipeline of products create a solid foundation for medium to long term international growth.

Built on legacy of affordability and access, portfolio emphasis on oral Beta lactam, Cephalosporin’s, Softgel formulations along with coming up chronic therapies like cardiology and diabetology.

With over 3 decades of experience, Indchemie today is amongst the world’s leading manufacturer of Softgel, Beta Lactam and Cephalosporin’s products. Our products pipeline is guided by our strategy intended in developing unique Softgel formulations for prescription, OTC and Nutraceuticals markets. We are amongst few of the recognized player know for high-quality products across the Emerging Markets and our plans are underway to enter stringent regulated markets very soon.

SoutheastAsia

In Southeast Asia, Indchemie exports its pharmaceutical products to the Philippines, Vietnam, Srilanka, Myanmar, Cambodia, and Thailand. These countries form part of a focused effort to ensure access to quality medicines across the region, where the company adapts its offerings to local healthcare needs and treatment protocols.

Africa

In Africa, Indchemie has a strong presence in Kenya and Tanzania, and it also serves markets including Kenya, Tanzania, Ethiopia, Nigeria, Uganda, Ghana, Zambia, and Botswana. These countries represent key areas of opportunity where Indchemie delivers essential therapies such as anti-malarias to support urgent healthcare priorities.

Latin America

Indchemie’s reach in Latin America includes exports to Ecuador, Chile, and Bolivia, showcasing the company's commitment to meeting healthcare demands across diverse populations.

Carribean

In the Caribbean, Indchemie exports to Jamaica, providing reliable and quality pharmaceutical products to support regional healthcare systems.

CIS Countries

Indchemie has expanded into CIS countries including Kazakhastan, Turkmenistan, Russia, Azerbaijan, Armenia, and Belarus, emphasizing its growing global presence and dedication to improving access to healthcare across Eurasia.